Back to search

Spain· ES:84570

OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA ALTER 40 MG/10 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

A medicinal product containing olmesartán + amlodipino + hidroclorotiazida, registered in Spain by Laboratorios Alter S.A..

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedOLMESARTAN/AMLODIPINO/HIDROCLOROTIAZI…ATC—REGISTER NO.ES:84570PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

AEMPS CIMA (Spain)
Active substance
olmesartán + amlodipino + hidroclorotiazida
Manufacturer
Laboratorios Alter S.A.
Country
Spain (ES)
ATC code
—
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cima_codigo
    727179
    28
    EUR 22.62

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Olmesartán + amlodipino + hidroclorotiazida in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All olmesartán + amlodipino + hidroclorotiazida products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bc1818e0-a2a5-4e6f-a15f-758121931296
GET /v1/drugs/bc1818e0-a2a5-4e6f-a15f-758121931296?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Medicamento Sujeto A Prescripción Médica",
  "estado": "{\"aut\":1571328409000}",
  "nregistro": "84570",
  "substance": "olmesartán + amlodipino + hidroclorotiazida"
}

See everything about olmesartán + amlodipino + hidroclorotiazida.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.